Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kaatz

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Pharmacotherapy|November 6, 2012
Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgeryCharles E Mahan, Scott Kaatz
The Medical Clinics of North America|December 19, 2003
Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?Daniel J Brotman, Scott Kaatz
Thrombosis Research|August 26, 2020
COVID-19 versus HIT hypercoagulabilityTheodore E Warkentin, Scott Kaatz
Hospital Practice (1995)|September 2, 2011
Venous thromboembolism prophylaxis after hospital discharge: transition to preventive careScott Kaatz, Alex C Spyropoulos
The American Journal of Medicine|August 31, 2016
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal AgentsTruman J Milling, Scott Kaatz
Journal of Thrombosis and Thrombolysis|March 5, 2013
Top practice-changing articles over the last two yearsScott Kaatz, Brian F Gage
Stroke|June 28, 2014
Stroke prevention in patients with atrial fibrillation and renal dysfunctionScott Kaatz, Charles E Mahan
Cleveland Clinic Journal of Medicine|September 3, 2011
Venous thromboembolism: what to do after anticoagulation is startedScott Kaatz, Waqas Qureshi, Robert C Lavender
Hematology. American Society of Hematology. Education Program|December 10, 2021
Perioperative consultative hematology: can you clear my patient for a procedure?Allison Elaine Burnett, Bishoy Ragheb, Scott Kaatz
The Journal of the American Osteopathic Association|December 8, 2010
Duration of anticoagulation treatment in patients with venous thromboembolismScott Kaatz, Waqas Qureshi, Christopher Fain, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Pharmacotherapy|November 6, 2012
Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgeryCharles E Mahan, Scott Kaatz
The Medical Clinics of North America|December 19, 2003
Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?Daniel J Brotman, Scott Kaatz
Thrombosis Research|August 26, 2020
COVID-19 versus HIT hypercoagulabilityTheodore E Warkentin, Scott Kaatz
Hospital Practice (1995)|September 2, 2011
Venous thromboembolism prophylaxis after hospital discharge: transition to preventive careScott Kaatz, Alex C Spyropoulos
The American Journal of Medicine|August 31, 2016
Preclinical and Clinical Data for Factor Xa and "Universal" Reversal AgentsTruman J Milling, Scott Kaatz
Journal of Thrombosis and Thrombolysis|March 5, 2013
Top practice-changing articles over the last two yearsScott Kaatz, Brian F Gage
Stroke|June 28, 2014
Stroke prevention in patients with atrial fibrillation and renal dysfunctionScott Kaatz, Charles E Mahan
Cleveland Clinic Journal of Medicine|September 3, 2011
Venous thromboembolism: what to do after anticoagulation is startedScott Kaatz, Waqas Qureshi, Robert C Lavender
Hematology. American Society of Hematology. Education Program|December 10, 2021
Perioperative consultative hematology: can you clear my patient for a procedure?Allison Elaine Burnett, Bishoy Ragheb, Scott Kaatz
The Journal of the American Osteopathic Association|December 8, 2010
Duration of anticoagulation treatment in patients with venous thromboembolismScott Kaatz, Waqas Qureshi, Christopher Fain, et al.
Pageof 16